Host-targeting oral antiviral drugs to prevent pandemics

被引：13
|
作者：
Dwek, Raymond A. [1 ]
Bell, John I. [2 ]
Feldmann, Marc [3 ,4 ]
Zitzmann, Nicole [1 ]
机构：
[1] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England
[2] Univ Oxford, Div Med Sci, Oxford OX1 3QU, England
[3] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX1 3QU, England
[4] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford OX1 3QU, England
来源：
LANCET | 2022年 / 399卷 / 10333期
关键词：
N-BUTYLDEOXYNOJIRIMYCIN; GLYCOSYLATION; COMBINATION; INFECTION; VIRUS;
D O I：
10.1016/S0140-6736(22)00454-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [31] Use of antiviral drugs to prevent herpesvirus transmission
    Crumpacker, CS
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01): : 67 - 68
  • [32] Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents
    Gallay, Philippe A.
    IMMUNOLOGIC RESEARCH, 2012, 52 (03) : 200 - 210
  • [33] Host-targeting therapies for hepatitis C virus infection: current developments and future applications
    Crouchet, Emilie
    Wrensch, Florian
    Schuster, Catherine
    Zeisel, Mirjam B.
    Baumert, Thomas F.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [34] A Screen of Host-Targeting Compounds identifies Potential Inhibitors of Zika Virus Infection.
    Khachatoorian, R.
    Arumugaswami, V.
    French, S. W.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [35] Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents
    Philippe A. Gallay
    Immunologic Research, 2012, 52 : 200 - 210
  • [36] TARGETING OF ANTIVIRAL DRUGS BY COUPLING WITH PROTEIN CARRIERS
    FIUME, L
    BUSI, C
    MATTIOLI, A
    FEBS LETTERS, 1983, 153 (01) : 6 - 10
  • [37] TARGETING OF ANTIVIRAL DRUGS BOUND TO PROTEIN CARRIERS
    FIUME, L
    BUSI, C
    MATTIOLI, A
    SPINOSA, G
    CRC CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1988, 4 (04): : 265 - 284
  • [38] A HIGH-THROUGHPUT HDV INFECTION MODEL SYSTEM FOR SCREENING OF ANTIVIRALS AND HOST-TARGETING COMPOUNDS
    Verrier, E. R.
    Tawar, R. G.
    Schuster, C.
    Brino, L.
    Bach, C.
    Heydmann, L.
    Habersetzer, F.
    Doffoel, M.
    Mckeating, J.
    Sureau, C.
    Zeisel, M. B.
    Baumert, T. F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S128 - S129
  • [39] SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
    Gassen, Nils C.
    Papies, Jan
    Bajaj, Thomas
    Emanuel, Jackson
    Dethloff, Frederik
    Chua, Robert Lorenz
    Trimpert, Jakob
    Heinemann, Nicolas
    Niemeyer, Christine
    Weege, Friderike
    Hoenzke, Katja
    Aschman, Tom
    Heinz, Daniel E.
    Weckmann, Katja
    Ebert, Tim
    Zellner, Andreas
    Lennarz, Martina
    Wyler, Emanuel
    Schroeder, Simon
    Richter, Anja
    Niemeyer, Daniela
    Hoffmann, Karen
    Meyer, Thomas F.
    Heppner, Frank L.
    Corman, Victor M.
    Landthaler, Markus
    Hocke, Andreas C.
    Morkel, Markus
    Osterrieder, Nikolaus
    Conrad, Christian
    Eils, Roland
    Radbruch, Helena
    Giavalisco, Patrick
    Drosten, Christian
    Mueller, Marcel A.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [40] A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses
    Ching, Kuan-Chieh
    Ng, Lisa F. P.
    Chai, Christina L. L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (11) : 2973 - 2989
12345